Laurus Labs more than doubled its Q2 net profit as revenue rose 33.5% and EBITDA surged 86.3%. Jefferies raised its target price to Rs 2,100, while Kotak and Goldman Sachs retained Sell ratings, citing valuation concerns despite improving growth prospects. Market analysts and industry participants are closely tracking the development to assess its impact on consumer pricing, liquidity, and domestic business sentiment over the coming quarters.